NSE filing, NSE: PARASHLTH. Summary written from the filing by ALFA Finder's alert engine.
Paras Healthcare Ltd: key numbers
- Share price
- ₹774.20
- Market cap
- ₹8,377 Cr
- Revenue (annual)
- ₹1,606 Cr
- Net profit (annual)
- ₹43.83 Cr
- Promoter holding
- 63.95%
- FII holding
- 11.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paras Healthcare Ltd
All →Paras Healthcare Results Update
Paras Healthcare reported Q2 FY27 revenue of Rs. 510.9 crore, up 22.8% YoY, through a press release. These are its first results since its October 2026 listing.
Paras Healthcare Q2 FY27 Results: Net Profit ₹40.4 Cr, Up 225.8% YoY
Paras Healthcare Ltd reported revenue from operations of ₹510.9 Cr (+22.8% YoY) and net profit of ₹40.4 Cr (+225.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹40.4 Cr · +225.8% YoY
Paras Healthcare Board Meeting Date
Paras Healthcare will hold a board meeting on 5 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.
Paras Healthcare Capital Structure Change
360 ONE funds disclose conversion of 78.82 lakh pre-IPO unlisted Paras Healthcare shares into listed shares at 7.28% stake. No new shares were acquired; the holding remained unchanged post-listing.
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Paras Healthcare Other Announcement
Paras Healthcare files its quarterly shareholding pattern as of 28 October 2026. Promoter group holds about 63.95 percent of the company.
Other management change announcements
All →Kalpataru Projects International Management Change
Kalpataru Projects approved the appointment of Amit Uplenchwar as Joint Managing Director and CEO, effective January 1, 2027. The five-year term is subject to shareholder approval.
- Execution
- January 1, 2027 to December 31, 2031
Coforge Management Change
Coforge issued a postal ballot notice seeking shareholder approval to appoint Akhil Kumar Gupta as an Independent Director for five years. E-voting runs November 6 to December 5, 2026.
Ugro Capital Management Change
Ugro Capital's internal auditor Kavita Shedge resigned, effective 06-11-2026. Chandrakant Bhagwat was appointed Company Secretary and Compliance Officer, effective 01-12-2026.
Organic Coatings Management Change
Organic Coatings appointed Tejas Rajeshbhai Basrani as Chief Financial Officer, effective November 5, 2026. He brings over 15 years of finance, accounts and compliance experience.
Shriram Asset Management Company Management Change
Shriram Asset Management's board appointed Vikrant Gugnani as Executive Director (WTD) for 36 months from November 16, 2026. Two fund managers and a Principal Officer (PMS) were also appointed as senior management, effective November 6, 2026.
- Execution
- 36 months from 2026-11-16
Time Technoplast Management Change
Time Technoplast's board re-appointed Bharat Kumar Vageria as Executive Director and MD for 60 months from February 6, 2027. The filing reports a management reappointment only, with no financial figures.
- Execution
- 60 months from 2027-02-06